Hiroyuki Arai Selected Research

lysophosphatidylinositol acyltransferase

1/2021

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Arai Research Topics

Disease

70	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 05/2002
33	Neoplasms (Cancer) 01/2022 - 07/2002
30	Dementia (Dementias) 10/2019 - 08/2002
25	Cognitive Dysfunction 04/2020 - 03/2002
16	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2004
14	Inflammation (Inflammations) 06/2022 - 06/2002
12	Amyloid Plaque 09/2015 - 03/2004
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2004
10	Neoplasm Metastasis (Metastasis) 11/2021 - 07/2007
7	Pneumonia (Pneumonitis) 01/2021 - 09/2006
7	Cough 06/2011 - 07/2003
7	Aspiration Pneumonia 01/2010 - 07/2003
6	Bites and Stings (Sting) 01/2022 - 01/2016
6	Vitamin E Deficiency 11/2021 - 04/2010
6	Peritonitis 12/2014 - 08/2009
6	Myopia 02/2014 - 11/2004
5	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 07/2006
5	Cataract (Cataracts) 08/2021 - 05/2005
5	Infections 11/2020 - 11/2009
5	Parkinson Disease (Parkinson's Disease) 08/2016 - 08/2003
5	Stroke (Strokes) 10/2009 - 01/2005
4	Necrosis 01/2021 - 11/2005
4	Astigmatism 03/2017 - 11/2004
4	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 07/2004
3	Body Weight (Weight, Body) 01/2022 - 12/2002
3	Seasonal Allergic Rhinitis (Hay Fever) 01/2022 - 01/2020
3	Ataxia with vitamin E deficiency 11/2021 - 10/2003
3	Asthma (Bronchial Asthma) 01/2021 - 04/2012
3	Gliosis 01/2021 - 01/2018
3	Disease Progression 01/2020 - 11/2009
3	Hypersensitivity (Allergy) 11/2017 - 10/2007
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2009 - 08/2005
3	Pathologic Processes 01/2008 - 05/2002
3	Lissencephaly 10/2007 - 04/2003
3	Melanoma (Melanoma, Malignant) 07/2007 - 06/2006
3	Brain Infarction 07/2005 - 05/2004
2	Hypotension (Low Blood Pressure) 01/2022 - 11/2003

Drug/Important Bio-Agent (IBA)

29	Amyloid (Amyloid Fibrils)IBA 01/2018 - 11/2004
26	Biomarkers (Surrogate Marker)IBA 09/2021 - 05/2002
25	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2003
18	LipidsIBA 01/2022 - 10/2003
15	lysophosphatidic acidIBA 02/2008 - 07/2002
11	tau Proteins (tau Protein)IBA 04/2022 - 08/2002
11	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 05/2002
10	EnzymesIBA 11/2020 - 05/2006
9	Amyloid beta-PeptidesIBA 04/2022 - 12/2003
8	alkylglycerophosphoethanolamine phosphodiesteraseIBA 02/2008 - 07/2002
7	BenzoxazolesIBA 11/2014 - 03/2004
7	2- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazoleIBA 08/2013 - 04/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2009
6	Pharmaceutical PreparationsIBA 01/2021 - 03/2002
6	Vitamin E FDA LinkGeneric 01/2019 - 11/2009
6	alpha-tocopherol transfer proteinIBA 05/2010 - 10/2003
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 04/2012
5	thiamine triphosphorate (TTP)IBA 11/2021 - 11/2010
5	THK5351IBA 01/2021 - 02/2016
5	Biological ProductsIBA 01/2018 - 09/2006
5	Tocopherols (Tocopherol)IBA 10/2015 - 11/2010
5	ZymosanIBA 12/2014 - 02/2011
5	alpha-Tocopherol FDA Link 05/2010 - 10/2003
5	Messenger RNA (mRNA)IBA 09/2007 - 01/2004
5	Lysophosphatidic Acid ReceptorsIBA 01/2006 - 01/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 05/2006
4	AntioxidantsIBA 01/2022 - 10/2003
4	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2020
4	InterferonsIBA 01/2022 - 01/2016
4	AntigensIBA 09/2021 - 02/2008
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2013
4	ApolipoproteinsIBA 01/2018 - 05/2004
4	Apolipoproteins E (ApoE)IBA 01/2018 - 07/2006
4	Yi-Gan SanIBA 02/2017 - 02/2005
4	Choline (Choline Chloride)IBA 02/2016 - 07/2007
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2007 - 04/2004
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 11/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2020
3	Transferrin (beta 2 Transferrin)IBA 09/2021 - 01/2008
3	Interferon Type IIBA 01/2021 - 01/2016
3	CholesterolIBA 01/2021 - 08/2006
3	AcyltransferasesIBA 01/2021 - 11/2012
3	Monoamine Oxidase (MAO)IBA 01/2021 - 08/2018
3	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2021 - 01/2013
3	EicosanoidsIBA 11/2017 - 04/2005
3	Peptides (Polypeptides)IBA 08/2017 - 11/2012
3	SynucleinsIBA 08/2016 - 11/2009
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2016 - 12/2005
3	Carrier Proteins (Binding Protein)IBA 01/2014 - 07/2006
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 01/2013
3	Citric Acid (Citrate)FDA LinkGeneric 06/2011 - 09/2003
3	HomocysteineIBA 07/2006 - 05/2004
2	PlatinumIBA 01/2022 - 07/2019
2	Epoxy Compounds (Epoxides)IBA 01/2022 - 11/2017
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2021

Therapy/Procedure

33	Therapeutics 01/2022 - 07/2002
14	Drug Therapy (Chemotherapy) 01/2022 - 10/2017
7	Activities of Daily Living (ADL) 10/2018 - 07/2003
7	Laser In Situ Keratomileusis (LASIK) 02/2014 - 11/2004
4	Phakic Intraocular Lenses 08/2021 - 05/2005
3	Intravenous Injections 11/2014 - 03/2004
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2009 - 02/2005